It is a dynamic time in HIV prevention, with a new long-acting option and several other exciting approaches under clinical investigation. Here, I summarize key updates in the current HIV prevention landscape that have occurred over the past year.
The HIV treatment landscape saw continued progress through 2022 with exciting new data on existing and emerging strategies across various stages of HIV therapy, from initial ART to switch strategies for people with viral suppression, as well as options for people who have extensive treatment experience and multiclass drug resistance.
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.